Exploring mechanisms to optimise the duration of oral immunotherapy for peanut allergy
探索优化花生过敏口服免疫治疗持续时间的机制
基本信息
- 批准号:MR/W025639/1
- 负责人:
- 金额:$ 110.95万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2022
- 资助国家:英国
- 起止时间:2022 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Peanut allergy affects 1 in 30 children and is the commonest trigger for life-threatening reactions (anaphylaxis) in this age group. It is a major public health issue, with practical implications for industry, education and healthcare systems.Oral immunotherapy (OIT) is an emerging treatment option, where small, increasing doses of a food allergen are used to cause "desensitisation", so that patients no longer experience symptoms upon exposure to the food. However, frequent allergic reactions to OIT (including anaphylaxis) are common, and thus a limiting factor. Furthermore, treatment effect requires ongoing OIT dosing: over half of patients lose their desensitisation after stopping OIT for 4 weeks. This is a problem, as patients are usually averse to the taste of the food they are allergic too, which affects compliance and treatment success. Persistence of desensitisation, without the need for ongoing regular maintenance dosing, is arguably the most important outcome for patients and their families. The biological mechanism(s) underlying OIT - and in particular, the persistence of desensitisation - are unclear. This significantly limits our ability to identify patients who may need a different protocol to minimise adverse reactions, achieve longer-lasting desensitisation, and improve patient safety. Immunotherapy is widely undertaken for the treatment of hay fever and allergy to insect stings - where treatment success is dependent on the duration of treatment. We therefore expect that for food allergy, the duration of OIT may be of critical importance in achieving longer-term efficacy.In the Boiled Oral Peanut Immunotherapy (BOPI) study (NCT02149719; part-funded through an MRC Fellowship to TURNER), 75% of participants achieved the primary outcome for the study, and tolerated a dose of 1.4 grams peanut protein (approximately 6-8 peanuts) at double-blind, placebo-controlled food challenge after 1 year of treatment. 53% maintained their desensitisation after stopping peanut OIT for 4 weeks; this increased to 72% after up to 2 years of further maintenance treatment.PROJECT PLANWe will evaluate the impact of longer durations of peanut-OIT (up to 3 years) on changes in the immune system, and how this corresponds to clinical outcomes, including desensitisation (and whether this is sustained) and safety, in patients undergoing peanut-OIT. We will apply novel techniques to study not just the initial changes that result in desensitisation, but also what happens when patients subsequently stop OIT doses and the treatment effect may be lost. We have successfully applied this approach to hay fever immmunotherapy. We will therefore be able to better understand the impact of OIT on the immune system, and how the desensitisation effect is sustained. We will analyse blood samples which have been bio-banked from patients in the original BOPI study who have undergone OIT for up to 3 years (under existing ethics approval). Together with existing clinical and laboratory data from BOPI, this will form the most comprehensive dataset evaluating how duration of OIT impacts on both clinical and mechanistic outcomes. Where we identify key findings, we will seek to replicate (and therefore validate) these in a further peanut-OIT study (BOPI-2 study; NCT03937726; currently underway) which also follows patients through to 3 years).This robust approach will allow us to assess the mechanisms associated with both the induction and loss of desensitisation in peanut-allergic children undergoing up to 3 years of OIT. We will use machine learning approaches to understand how these immune changes correlate to clinical outcomes, and so build a model (including both patient characteristics and initial response to treatment) which can predict longer-term treatment outcomes. If successful, this will facilitate the personalisation of OIT protocols, maximising treatment success and leading to safer patient outcomes.
花生过敏影响30名儿童中的1名,并且是该年龄组中危及生命的反应(过敏反应)的最常见触发因素。口服免疫疗法(OIT)是一种新兴的治疗选择,通过小剂量、递增剂量的食物过敏原来引起“脱敏”,使患者在接触食物后不再出现症状。然而,对OIT的频繁过敏反应(包括速发型过敏反应)很常见,因此是一个限制因素。此外,治疗效果需要持续的OIT剂量:超过一半的患者在停止OIT 4周后失去脱敏作用。这是一个问题,因为患者通常不喜欢他们过敏的食物的味道,这会影响依从性和治疗成功。脱敏的持续性,而不需要持续的定期维持剂量,可以说是患者及其家属最重要的结果。OIT的生物学机制-特别是脱敏的持续性-尚不清楚。这大大限制了我们识别可能需要不同方案的患者的能力,以最大限度地减少不良反应,实现更持久的脱敏,并提高患者安全性。免疫疗法被广泛用于治疗花粉热和对昆虫叮咬的过敏-其中治疗成功取决于治疗的持续时间。因此,我们预计,对于食物过敏,OIT的持续时间可能是至关重要的,在实现长期疗效。(NCT02149719;部分资金通过MRC奖学金到特纳),75%的参与者实现了研究的主要成果,并且在治疗1年后,在双盲、安慰剂对照的食物攻击中耐受1.4克花生蛋白(大约6-8个花生)的剂量。停药4周后53%的患者保持脱敏效果;这增加到72%后,长达2年的进一步维护治疗。项目计划我们将评估的影响,更长的时间花生OIT(最多3年)免疫系统的变化,以及这如何对应于临床结果,包括脱敏(以及这种情况是否持续)和安全性,在接受花生OIT的患者中。我们将应用新技术来研究不仅是导致脱敏的最初变化,而且当患者随后停止OIT剂量时会发生什么,治疗效果可能会丧失。我们已经成功地将这种方法应用于花粉热免疫治疗。因此,我们将能够更好地了解OIT对免疫系统的影响,以及脱敏效应如何持续。我们将分析原始BOPI研究中接受OIT长达3年(根据现有伦理批准)的患者的生物库血液样本。结合BOPI现有的临床和实验室数据,这将形成最全面的数据集,评估OIT持续时间如何影响临床和机制结局。当我们确定了关键发现时,我们将在进一步的花生OIT研究(BOPI-2研究; NCT 03937726;目前正在进行中)中复制(并因此验证)这些研究,该研究也随访患者3年)。这种稳健的方法将使我们能够评估与花生过敏儿童接受长达3年的OIT的脱敏诱导和丧失相关的机制。我们将使用机器学习方法来了解这些免疫变化如何与临床结果相关,从而建立一个模型(包括患者特征和对治疗的初始反应),可以预测长期治疗结果。如果成功,这将促进OIT方案的个性化,最大限度地提高治疗成功率,并带来更安全的患者结局。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Impact of using less objective symptoms to define tolerated dose during food challenges: A data-driven approach
使用不太客观的症状来定义食物挑战期间耐受剂量的影响:数据驱动的方法
- DOI:10.1016/j.jaci.2022.12.818
- 发表时间:2023
- 期刊:
- 影响因子:14.2
- 作者:Turner P
- 通讯作者:Turner P
Flex-IT! Applying "Platform Trials" Methodology to Immunotherapy for Food Allergy in Research and Clinical Practice
- DOI:10.1016/j.jaip.2024.01.009
- 发表时间:2024-03-06
- 期刊:
- 影响因子:9.4
- 作者:Mack,Douglas P.;Upton,Julia;Turner,Paul J.
- 通讯作者:Turner,Paul J.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Turner其他文献
Journal Pre-proof Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off (ECOFF) values
期刊预证明类鼻疽伯克霍尔德氏菌多中心研究,旨在建立 EUCAST MIC 和区域直径分布以及流行病学截止值 (ECOFF)
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Onur Karatuna;David A. B. Dance;E. Matuschek;J. Åhman;Paul Turner;Jill;Hopkins;Premjit Amornchai;V. Wuthiekanun;Tomas;Rob Baird;Jann;Hennessy;Robert E Norton;Mark Armstrong;S. Zange;Lothar Zoeller;Tara Wahab;D. Jacob;Roland Grunow;Gunnar Kahlmeter - 通讯作者:
Gunnar Kahlmeter
Influence of debrisoquine hydroxylation phenotype on the pharmacokinetics of mexiletine
异喹啉羟基化表型对美西律药代动力学的影响
- DOI:
- 发表时间:
2004 - 期刊:
- 影响因子:2.9
- 作者:
P. Lledo;S. Abrams;Atholl Johnston;Mahesh Patel;R. Pearson;Paul Turner - 通讯作者:
Paul Turner
Molecular Epidemiology of Group A Streptococcus Infections in Cambodian Children, 2007–2012
2007-2012 年柬埔寨儿童 A 组链球菌感染的分子流行病学
- DOI:
- 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
Paul Turner;P. Ngeth;Claudia Turner;Sena Sao;Nicholas P. J. Day;C. Baker;Andrew C. Steer;P. Smeesters - 通讯作者:
P. Smeesters
Routine versus selective contrast imaging to identify the need for early re-intervention following laparoscopic fundoplication: A retrospective cohort study
- DOI:
10.1016/j.ijsu.2015.06.052 - 发表时间:
2015-08-01 - 期刊:
- 影响因子:
- 作者:
Khalid Shahzad;Ashok Menon;Paul Turner;Jeremy Ward;Kishore Pursnani;Bilal Alkhaffaf - 通讯作者:
Bilal Alkhaffaf
Water management in sport
- DOI:
10.1016/j.smr.2013.08.002 - 发表时间:
2014-08-01 - 期刊:
- 影响因子:
- 作者:
Pamm Phillips;Paul Turner - 通讯作者:
Paul Turner
Paul Turner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Turner', 18)}}的其他基金
MICA: Identifying risks for severe life-threatening allergic reactions to foods (IRIS-Allergy)
MICA:识别严重危及生命的食物过敏反应的风险(IRIS-Allergy)
- 批准号:
MR/W018616/1 - 财政年份:2022
- 资助金额:
$ 110.95万 - 项目类别:
Research Grant
Improved diagnostics in food allergy (ID-in-FA) Study
改进食物过敏诊断 (ID-in-FA) 研究
- 批准号:
MR/S036954/1 - 财政年份:2019
- 资助金额:
$ 110.95万 - 项目类别:
Research Grant
2013 Microbial Population Biology GRC/GRS
2013年微生物种群生物学GRC/GRS
- 批准号:
1314149 - 财政年份:2013
- 资助金额:
$ 110.95万 - 项目类别:
Standard Grant
Mechanisms underlying the physiological and cellular response to food allergen challenge in human subjects with peanut allergy
花生过敏人类受试者对食物过敏原挑战的生理和细胞反应的机制
- 批准号:
MR/K010468/1 - 财政年份:2013
- 资助金额:
$ 110.95万 - 项目类别:
Fellowship
DISSERTATION RESEARCH: The proximate basis of behavioral plasticity in the butterfly Bicyclus anynana
论文研究:蝴蝶 Bicyclus annana 行为可塑性的直接基础
- 批准号:
1110523 - 财政年份:2011
- 资助金额:
$ 110.95万 - 项目类别:
Standard Grant
Effects of host-use traits on RNA virus evolvability
宿主使用特征对 RNA 病毒进化能力的影响
- 批准号:
1051093 - 财政年份:2011
- 资助金额:
$ 110.95万 - 项目类别:
Continuing Grant
DISSERTATION RESEARCH: Pre-mating experience influences female mate preference in the butterfly Bicyclus anynana
论文研究:交配前经历影响蝴蝶 Bicyclus annana 的雌性交配偏好
- 批准号:
1110382 - 财政年份:2011
- 资助金额:
$ 110.95万 - 项目类别:
Standard Grant
DISSERTATION RESEARCH: Life History Coevolution Between an Aging Bacterium and its Bacteriophage
论文研究:衰老细菌与其噬菌体之间的生命史共同进化
- 批准号:
0608398 - 财政年份:2006
- 资助金额:
$ 110.95万 - 项目类别:
Standard Grant
Environmental Variability and Evolution of Virus Specialists and Generalists
环境变化以及病毒专家和通才的进化
- 批准号:
0452163 - 财政年份:2005
- 资助金额:
$ 110.95万 - 项目类别:
Continuing Grant
DISSERTATION RESEARCH: Evolution of Generalism and Specialism in the RNA phage Phi6
论文研究:RNA 噬菌体 Phi6 的通用性和专业性的进化
- 批准号:
0408000 - 财政年份:2004
- 资助金额:
$ 110.95万 - 项目类别:
Standard Grant
相似国自然基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
- 批准号:
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国学者研究基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
- 批准号:W2433169
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国学者研究基金项目
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
- 批准号:82371255
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
- 批准号:82370979
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
- 批准号:82370981
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
- 批准号:82370851
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
- 批准号:82371248
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
- 批准号:82371973
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
- 批准号:82371652
- 批准年份:2023
- 资助金额:45.00 万元
- 项目类别:面上项目
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
- 批准号:82372015
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
相似海外基金
Unlocking the mechanisms of vibro-acoustic communication in termites
解锁白蚁振动声学通讯机制
- 批准号:
DP240101536 - 财政年份:2024
- 资助金额:
$ 110.95万 - 项目类别:
Discovery Projects
Noise-reduction mechanisms in jet engines: chevrons are the answer
喷气发动机的降噪机制:人字形就是答案
- 批准号:
DE240100933 - 财政年份:2024
- 资助金额:
$ 110.95万 - 项目类别:
Discovery Early Career Researcher Award
Governing Sustainable Futures: Advancing the use of Participatory Mechanisms for addressing Place-based Contestations of Sustainable Living
治理可持续未来:推进利用参与机制来解决基于地方的可持续生活竞赛
- 批准号:
ES/Z502789/1 - 财政年份:2024
- 资助金额:
$ 110.95万 - 项目类别:
Research Grant
PriorCircuit:Circuit mechanisms for computing and exploiting statistical structures in sensory decision making
PriorCircuit:在感官决策中计算和利用统计结构的电路机制
- 批准号:
EP/Z000599/1 - 财政年份:2024
- 资助金额:
$ 110.95万 - 项目类别:
Research Grant
GPR35: mechanisms of action and agonism as a potential therapeutic strategy for non-alcoholic fatty liver diseases
GPR35:作为非酒精性脂肪肝疾病潜在治疗策略的作用和激动机制
- 批准号:
MR/X008827/1 - 财政年份:2024
- 资助金额:
$ 110.95万 - 项目类别:
Research Grant
Mechanisms of Motivation: The Role of Cortical-Basal Ganglia-Dopamine Circuits in Reward Pursuit and Apathy
动机机制:皮质-基底神经节-多巴胺回路在奖励追求和冷漠中的作用
- 批准号:
MR/X022080/1 - 财政年份:2024
- 资助金额:
$ 110.95万 - 项目类别:
Research Grant
Understanding the mechanisms underlying the detrimental effects of NAFLD on the brain
了解 NAFLD 对大脑产生有害影响的机制
- 批准号:
MR/X033287/1 - 财政年份:2024
- 资助金额:
$ 110.95万 - 项目类别:
Fellowship
Mechanisms underlying homeotic function across developmental transitions
发育转变过程中同源异型功能的潜在机制
- 批准号:
BB/Y006860/1 - 财政年份:2024
- 资助金额:
$ 110.95万 - 项目类别:
Research Grant
Understanding the mechanisms underlying noise-induced damage of hair cell ribbon synapses
了解噪声引起的毛细胞带突触损伤的机制
- 批准号:
BB/Z514743/1 - 财政年份:2024
- 资助金额:
$ 110.95万 - 项目类别:
Fellowship
Neuronal mechanisms for social information processing.
社会信息处理的神经机制。
- 批准号:
BB/Z514780/1 - 财政年份:2024
- 资助金额:
$ 110.95万 - 项目类别:
Fellowship